JAN 31
New Users Please Click to Register
Renew or Upgrade your Existing  Account

Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    RRI-2014  :  Brigham-2013  :  ISHD Shanghai-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-Chicago-2012/14  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
free ISHD Hemodialysis University Chicago (2012-2014)
free ISHD Hemodialysis University Shanghai 2013
free ISHD Hemodialysis University Chicago (2014)
free ISHD Hemodialysis University India (2014)


Brigham Nephrology Board Review Course.   
Flash or IPAD slide/audio
Boston, MA; August, 2013

Key Transplant Studies - What to Know for the Boards: Parts 1 and 2
Anil Chandraker, MD




ISHD Hemodialysis University Chicago 2014   
Flash or IPAD slide/audio
International Society for Hemodialysis
Chicago, IL; August, 2014


PART ONE. Left Ventricular Hypertrophy and Intradialysis
Left Ventricular Hypertrophy Improvement with Intensive Daily HD
Christopher T Chan MD

Intradialysis Hypotension, Dialysis Cardiomyopathy (Stunning) and Dialysis Temperature
Chris McIntyre, MD




ISHD Hemodialysis University India 2014   
Flash or IPAD slide/audio
International Society for Hemodialysis
Hyderabad, India; March, 2014


Opening and Welcome
Madhukar Misra, MD

Hemodialysis adequacy - 'nuts and bolts'
John T. Daugirdas, MD

Hemodialysis adequacy. Kt/V and beyond
John T. Daugirdas, MD


Hypertension, Cardiovascular
Vitamin D for HTN and pre-HTN
Neprilysin better than enalapril alone for HF
Circulating aldo in healthies
Evelocumab for hetero- or homozygous familial CHO elevation
Genetic marker of uric acid and CV outcomes
Dietary nitrates may really work for HTN!

CKD, Dialysis
Adverse technical events in home HD
Hospitalization in daily home HD
When to operate for infective endocarditis
Pentoxifylline in diabetic kidney disease
Olive or flaxseed oil for constipation in HD
High IV iron and mortality in DOPPS
Very low protein diet plus ketoacids is OK
Canadian comments on KDIGO CKD guidelines
FGF23 and antiproteinuric effects of low-sodium diet
Renal replacement therapy for AKI may harm
Dietary protein and fiber in ESRD (review, key)

Clinical Nephrology
Tonsillectomy for IGAN (meta)
Multitarget induction Rx for lupus
Congenital heart defects in babies born to mothers with lupus
RBC 2,3 DPG concentration gets depleted by CRRT
Diabetic kidney disease: KDIGO update
Longer prednisolone treatment for kids with SS nephrotic syndrome no good
Rituximab in kids with difficult nephrotic syndrome
Serum potassium levels before access procedures

This update's selected ASN 2014 abstracts

Sustained dietary sodium reduction lowers albuminuria; Systolic BP in the elderly as a risk factor; Metformin in different stages of CKD.

Postdialysis anaphylaxis from alginate compression dressing; Clinical assessment of hypovolemia no good; BIA analysis and hypertension in dialysis patients; BMI may alter fluid status norms by BIA; Inaccuracy of plasma Na measurements in dialysis patients; Peritonitis is a risk factor for CV mortality; Circulating bacterial DNA bad in PD patients; BIA-guided volume management in PD; Thiazides and amiloride reduce proteinuria in CKD (!!); Novel side effects of Ferrlecit in predialysis CKD; RBC transfusion markedly increases K in advanced CKD; dietary acid reduction good in stage 1 CKD; Plant-based diet on MBD and muscle in CKD; Menatetrenone + risedronate attenuates glucocorticoid-induced osteoporosis (!!); Kinetic model for intradialytic calcium; Where the the Pi during dialysis come from? Tenapanor inhibits Pi absorption in rats and humans; Warfarin promotes vascular calcification; Sodium thiosulfate for calciphylaxis; False positive Down's syndrome in pregnant women with CKD; HUS in dialysis patients; Nalbuphine for pruritus in ESRD.

Clinical Nephrology
Biologic variation in serum creatinine in AKI; Renal tubular secretion in CKD; Ethylene glycol toxicity masquerading as lactic acidosis; Hyperlactatemia due to thiamine deficiency; Once daily ZS-9 for hyperkalemia; High uric acid a risk for AKI in the elderly; HUS due to STEC 12 month follow-up; Synthetic cannabinoids and AKI or rhabdomyolysis; Iced tea nephropathy; Chronic nephropathy from dietary hyperoxaluria; Magnesium to protect kidneys against cisplatin; Novel risk score for contrast nephropathy;

Rituximab for relapsing minimal change disease; biannual single-dose rituximab regimen; Low-dose prednisolone plus cyclosporine for MCD; Rituximab plus cyclosporine for idiopathic membranous; IGAN with low complement 4 levels; Anti-CD20 monoclonal antibody for ANCA vasculitis; Rituximab for ANCA vasculitis; Oral C5aR inhibitor CCS 168 for ANCA vasculitis. An oral enzyme reduces dietary hyperoxaluria; Oxilobacter formigenes colonization for gastric bypass hyperoxaluria; Recipient donor gender combinations and body size effects on allograft survival.  (Kidney Week 2014...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: February 26, 2015 (Feb26)
Feb26 AKI electronic alert system backfires and increases interventions without improving outcomes.
Feb26 Medtronic to launch new phase II trial of renal nerve ablation (Symplicity device)
Feb26 Dabigatran has higher bleeding risk than warfarin in dialysis patients
Feb26 Blue-green algae (cyanobacteria) proliferating in lakes worldwide.
Feb26 Polysorbate 80 and carboxymethylcellulose - food emulsifiers, and metabolic syndrome
Feb25 The concept of minimizing regret in poker: an application for medical treatment?
Feb21 US Government radically changing dietary advice
Feb20 Bourbon virus - a previously unknown Thogotovirus, associated with AKI after tick bite.
Feb12 Rapamycin in bloomberg.com as an anti-ageing drug.
Feb05 BMJ study: Intensify BP treament when SBP > 150, but do it promptly.
Feb05 Rapid and unexpected weight gain after fecal transplant
Jan26 Hemodialysis abstracts from the upcoming Annual Dialysis Conference in New Orleans
Jan24 FDA committee recommends approval of drug to treat invasive aspergillosis.
Jan09 New variant of aminoglycosides does not impair hearing.
Jan09 Monthly dose of PCSK9 inhibitor lowers serum cholesterol
Dec19 Ibuprofen extends lifespan in yeast., worms, and fruit flies.
Nov18 Ultrasonography for nephrologists course Jan 10-11, 2015
Nov17 JAMA: New hyperkalemia sorbent effective in reducing hyperkalemia
Nov08 Fiber supplementation lower p-cresol levels
Nov06 Google genomics: storing thousands of genomes in the cloud
General Advances Emphasis
Unnecessary renal replacement therapy for acute kidney injury is harmful for renal recovery
Drs. Clark and Bagshaw discuss the potential harms of dialysing patients with suspected AKI too early; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Dietary protein and fiber in end stage renal disease
Tammy Sirich talks about dietary protein, fiber, gut transit time, and gut microbes in uremia, and new ways to modulate blood levels of indoxyl sulfate and p-cresyl sulfate; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Thyroid function tests in end stage renal disease.
Drs. Kulkarni and Holley describe the emerging evidence that thyroid dysfunction should be sought and perhaps treated in dialysis patients; in the Nov/Dec issue of Seminars in Dialysis, which has articles about the usefulness of many other laboratory tests in ESKD as well.. (more...)

Hypomagnesemia, chronic kidney disease and cardiovascular mortality: Pronounced association but unproven causation
Dr. Dousdampanis and colleagues review the latest evidence regarding low magnesium and CKD, and whether we should treat it; in the October issue of Hemodial Int (more...)

Sailing between Scylla and Charybdis: The high serum K - low dialysate K quandary
Should we use a 3 K bath for most patients? Are 1K and zero K bath's a no-no? Drs. Labriola and Jadoul review the evidence in the Sept/Oct issue of Seminars in Dialysis. (more...)

A stepwise approach for the management of poisoning with extracorporeal treatments Few are using hemoperfusion anymore, and poisoning requires an integrated approach. Dr. Ghannoum and colleagues provide a nice overview in the July/Aug issue of Seminars in Dialysis. (more...)

Hemodialysis for infants, children, and adolescents
Drs. Kaur and Davenport review techniques for performing hemodialysis in children; in the July issue issue of Hemodial Int (more...)

Urgent-start peritoneal dialysis: what are the problems and their solutions? Dr. Mahnensmith discusses this new approach to AKI or acute-on-chronic kidney failure, its advantages and potential problems; in the May/June issue of Seminars in Dialysis. (more...)

Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome
Dr. Sands and colleagues delve into large databases to better understand the occurrence and risk factors for intradialytic hypotension; in the April issue of Hemodial Int (more...)

Hemodialysis-associated cardiomyopathy: a newly defined disease entity Drs. McIntyre and Odudu describe their latest results regarding myocardial stunning; in the Mar/Apr issue of Seminars in Dialysis. (more...)

Nonadherence in dialysis patients: prevalence, measurement, outcome, and psychological determinants Dr. Clarke and colleagues review why adherence is so important to outcomes, and methods that have been suggested to improve this problem; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Approach to prophylactic measures for central venous catheter- related infections in hemodialysis: A critical review
Dr. Silva and colleagues go over what we know works, and which treatments are still experimental; in the Jan-Feb issue of Hemodial Int (more...)

Infrequent dialysis: a new paradigm for hemodialysis initiation Dr. Rhee and colleagues present a novel idea; starting out with twice-a-week dialysis in incident patients with substantial residual kidney function, and discuss potential benefits vs. risks. in the Nov/Dec issue of Seminars in Dialysis. (more...)

  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

  Advances in CKD (Renal Research Institute) (2014) (2013) (2012) (2011) (2010) (2009)
  Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
  The Brigham Renal Board Review Course: Selected Lectures (2013) -- (2012) -- (2011)
  American Society of Hypertension (2013)   (2012)   (2011)
  Renal Physicians Association (2012) (2011) (2010) (2009)
  American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
  Fistula First (2010)
  Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
  National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
  American Society for Nephrology Renal Week (2009) (2008) (2007)
  American Society for Nephrology Board Review Course (2008) (2007)
  American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99